Psoriasis kliniske forsøg i Ohio
9 studier for Psoriasis søger deltagere på steder i Ohio.
Byer i Ohio
Officiel studietekst (engelsk)
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
- LEO Pharma Investigation Site, Mayfield Heights
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07013201Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Optima Research - Boardman, Boardman
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT06857942Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors
- University Hospitals Cleveland Medical Center, Cleveland
Rekrutterer
Alder 18 til 94 · Alle køn · Opdateret 4. sep. 2026 · NCT06399432A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Apex Clinical Research Center - Canton, Canton
- Apex Clinical Research Center, Lorain
- Apex Clinical Research Center, Mayfield Heights
RekruttererFase 3
Alder 12 til 17 · Alle køn · Opdateret 3. sep. 2026 · NCT06979453A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
- Ppp001 50745, Columbus
- Ppp001 50202, Fairborn
- Ppp001 50733, Mayfield Heights
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 27. aug. 2026 · NCT07219420A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
- Study Center, Mayfield Heights
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 9. jul. 2026 · NCT07489885Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
- University Hospitals Cleveland Medical Center, Cleveland
RekruttererFase 4
Alder 18 til 89 · Alle køn · Opdateret 2. apr. 2026 · NCT05270733IMPACT - AndHealth Autoimmune Research Registry
- AndHealth, Columbus
RekruttererObservationsstudie
Alder 18 til 70 · Alle køn · Opdateret 29. jun. 2023 · NCT05883371Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.